Institutions · Entity Annotation Prototype (beta)

3articles mentioning institutions

3institution mentions

1distinct institutions extracted

0%of mentions human-reviewed

Active filtersEntity: Eur J Gastroenterol Hepatol ×

Eur J Gastroenterol Hepatol

This institution is selected. Its supporting articles are shown below.

Eur J Gastroenterol Hepatol3

Articles mentioning Eur J Gastroenterol Hepatol

3 articles · page 1 of 1

OC89 Review of children with helicobacter pylori infection in south-west London

flgastro · abstract · 2026-06-29 · 1 matching annotations

83.9%

Eur J Gastroenterol Hepatol gastric cancer peptic ulcer disease chronic gastritis omeprazole clarithromycin amoxicillin metronidazole Atrophic gastritis eradication therapy

… of socioeconomic status and other confounders: a cohort study. Eur J Gastroenterol Hepatol. 2018 Feb;30(2):143–8.Abstract OC89 Figure 1…

P113 Investigating the association between rifaximin prescription rates and socioeconomic factors in Northern Ireland

gutjnl · abstract · 2025-10-06 · 1 matching annotations

86.1%

National Institute of Health and Care Excellence RStudio Eur J Gastroenterol Hepatol Rifaximin metabolic dysfunction-associated steatotic liver disease alcohol-related liver disease hepatic encephalopathy

…analysis. Eur J Gastroenterol Hepatol. 2022 Jun 1;34(6):671–677.National Institute of Health and Care Excellence. Rifaximin for preventing episodes of overt hepatic encephalopa…

OC33 Comparison of anti-TNF treatment in paediatric patients with ulcerative colitis: adalimumab vs infliximab in a five-year retrospective audit from a regional cohort

flgastro · abstract · 2025-08-20 · 1 matching annotations

78.7%

Inflamm Bowel Dis Eur J Gastroenterol Hepatol specialised centre Infliximab Adalimumab

…rability of infliximab in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2014;20:606–13. 194.Volonaki E, Mutalib M, Kiparissi F, et al.…